CRISTY KU to Genetic Therapy
This is a "connection" page, showing publications CRISTY KU has written about Genetic Therapy.
Connection Strength
1.873
-
Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. Transl Vis Sci Technol. 2024 Jun 03; 13(6):11.
Score: 0.651
-
The new landscape of retinal gene therapy. Am J Med Genet C Semin Med Genet. 2020 09; 184(3):846-859.
Score: 0.502
-
Gene Therapy Trial Update: A Primer for Vitreoretinal Specialists. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan; 47(1):6-12.
Score: 0.363
-
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5. Am J Ophthalmol. 2022 08; 240:285-301.
Score: 0.139
-
Stargardt Disease: Gene Therapy Strategies for ABCA4. Int Ophthalmol Clin. 2021 10 01; 61(4):157-165.
Score: 0.135
-
Viral-mediated vision rescue of a novel AIPL1 cone-rod dystrophy model. Hum Mol Genet. 2015 Feb 01; 24(3):670-84.
Score: 0.083